President Donald Trump (Jim Watson/AFP via Getty Images)
February 14, 2025 12:58 PM ESTUpdated 01:10 PM
Pharma
FDA+

Ex­clu­sive: Drug­mak­ers plan Trump meet­ing next week amid Wash­ing­ton health shake­ups

Drew Armstrong

Executive Editor

Ma­jor drug­mak­ers are plan­ning to meet with Pres­i­dent Don­ald Trump next week at the White House as part of the in­dus­try’s ef­fort to work with …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

Health­care shake­up hits Wash­ing­ton, with cuts at CDC, NIH and oth­er agen­cies

Ko­jin Ther­a­peu­tics shuts down, cit­ing lack of in­vestor in­ter­est and com­plex sci­ence

ARPA-H chief is out as Trump ad­min­is­tra­tion cuts health agen­cies

BioN­Tech vets raise $90M Se­ries A for bis­pe­cif­ic I&I start­up

Up­dat­ed: Mod­er­na re­ports $238M man­u­fac­tur­ing write-down as cuts, new vac­cines shape 2025

sponsored

Re­duc­ing risk in drug de­vel­op­ment: The im­por­tance of val­i­dat­ed MRD test­ing in lym­phoid can­cers

A service from the Financial Times